Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC
Clinical trial NCT04691947 · COMPLETED
Trial details
- NCT number
- NCT04691947
- Sponsor
- Health Institutes of Turkey
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-05
- Primary completion
- 2021-11-18
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.